Suppr超能文献

非甾体抗炎药在 LASIK 术后因创伤性瓣移位导致角膜上皮内植入中的应用:病例报告。

Use of nonsteroidal anti-inflammatory drugs in corneal epithelial ingrowth due to traumatic flap dislocation after LASIK: Case report.

机构信息

Department of Ophthalmology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.

出版信息

Medicine (Baltimore). 2024 Mar 1;103(9):e37333. doi: 10.1097/MD.0000000000037333.

Abstract

RATIONALE

Ophthalmologists mainly treat epithelial ingrowth by lifting the flap and scraping the ingrowth or using scraping combined with phototherapeutic keratectomy, mitomycin C, and so on. The potential usefulness of nonsteroidal anti-inflammatory drugs in such circumstances has not been reported before.

PATIENT CONCERNS

A 32-year-old man and a 25-year-old man underwent lifting and scraping of the flap and phototherapeutic keratectomy to remove the epithelial ingrowths. Unfortunately, the ingrowths recurred and continued to develop.

DIAGNOSIS

The patients were diagnosed with corneal epithelial ingrowth.

INTERVENTIONS

The administration of bromfenac sodium and fluorometholone eye drops.

OUTCOMES

Epithelial ingrowths in both patients disappeared after 6 and 1 month of treatment, respectively. There were no adverse reactions to the eye drops.

LESSONS

Nonsteroidal anti-inflammatory drugs may be broadly applied in the treatment of epithelial ingrowth after laser in situ keratomileusis.

摘要

背景

眼科医生主要通过掀起角膜瓣并刮除赘生物,或采用刮除联合光动力角膜切削术、丝裂霉素 C 等方法治疗角膜上皮内植入物。然而,此前尚未有研究报道非甾体类抗炎药在这种情况下的潜在用途。

患者关注

两名患者,分别为 32 岁男性和 25 岁男性,均接受了掀起角膜瓣和光动力角膜切削术以去除角膜上皮内植入物。遗憾的是,植入物复发并持续发展。

诊断

患者被诊断为角膜上皮内植入物。

干预措施

给予溴芬酸钠和氟米龙滴眼液滴眼。

结果

两名患者在接受治疗 6 个月和 1 个月后,角膜上皮内植入物均消失,且未见滴眼液相关不良反应。

结论

非甾体类抗炎药可能广泛应用于激光原位角膜磨镶术后角膜上皮内植入物的治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验